McKesson Corporation

NYSE:MCK Lagerbericht

Marktkapitalisierung: US$76.7b

McKesson Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

38.5%

Wachstumsrate der Gewinne

41.8%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie8.5%
Wachstumsrate der Einnahmen7.1%
Eigenkapitalrenditen/a
Netto-Marge1.0%
Letzte Ertragsaktualisierung31 Mar 2024

Jüngste Aktualisierungen vergangener Leistungen

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Feb 16
McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Recent updates

With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

May 09
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Mar 14
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

Feb 19

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Feb 16
McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

Jan 29
Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

Jan 19

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

Nov 20
If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Nov 08

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

Oct 30
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson: Still Trading For A Huge Discount

Sep 06

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Aug 21
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

Jul 27
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

Jun 28

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

May 23
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Apr 17
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Feb 22
Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

Feb 08

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12
McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

Sep 19
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

McKesson to acquire Rx Savings Solutions in $875M deal

Sep 19

Cardinal Health, McKesson hit 52-week highs; up 35% and 50% YTD

Aug 15

McKesson raises fiscal 2023 adjusted diluted EPS following strong quarterly results

Aug 03

McKesson raises dividend by 15% to $0.54/share

Jul 25

McKesson Is Still An Attractive Dividend Growth Stock

Jul 10

McKesson: Best Of Breed In Drug Distributor Oligopoly

Jun 20

Aufschlüsselung der Einnahmen und Ausgaben

Wie McKesson Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

NYSE:MCK Einnahmen, Ausgaben und Erträge (USD Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
31 Mar 24308,9513,0028,0100
31 Dec 23301,5062,9987,7850
30 Sep 23291,0983,4877,8380
30 Jun 23284,0403,7557,8810
31 Mar 23276,7113,5637,9800
31 Dec 22273,9033,1468,2580
30 Sep 22272,0272,0618,4380
30 Jun 22268,4461,3968,7020
31 Mar 22263,9661,1198,9370
31 Dec 21257,0061,4158,9180
30 Sep 21250,991-4,8048,9260
30 Jun 21245,223-4,4948,9190
31 Mar 21238,228-4,5388,7910
31 Dec 20237,621-4,1898,6960
30 Sep 20234,1942,2288,8750
30 Jun 20231,0029228,8640
31 Mar 20231,0519068,9070
31 Dec 19224,945-9059,64171
30 Sep 19221,981-6269,16071
30 Jun 19217,4406018,64271
31 Mar 19214,319338,4370
31 Dec 18213,518-3198,362125
30 Sep 18210,9271138,197125
30 Jun 18209,913-3848,300125
31 Mar 18208,357628,138125
31 Dec 17205,4424,8057,464341
30 Sep 17201,9554,5397,503341
30 Jun 17199,8514,8467,317341
31 Mar 17198,5335,1947,447341
31 Dec 16196,4982,0517,149392
30 Sep 16194,2672,0447,264392
30 Jun 16193,0712,3597,283392
31 Mar 16190,8842,2907,379392
31 Dec 15189,1312,2377,573392
30 Sep 15187,7162,0907,342392
30 Jun 15183,1151,9507,781392
31 Mar 15179,0451,7757,901392
31 Dec 14171,9521,7807,323457
30 Sep 14159,8041,4626,932457
30 Jun 14148,6291,4026,143457
31 Mar 14137,3921,4195,388457
31 Dec 13130,0761,2784,675433
30 Sep 13126,8391,4204,554433
30 Jun 13123,6091,3964,298433

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

7D

1Y

7D

1Y

7D

1Y